BioInvent is a Sweden-based biotechnology company that researches and develops antibody drugs for the treatment of cancer...
Read moreBioInvent is a Sweden-based biotechnology company that researches and develops antibody drugs for the treatment of cancer...
Read moreAnnual Revenue
$30.4M
BioInvent's revenue is the ranked 8th among it's top 10 competitors. The top 10 competitors average 18.5B. Over the last four quarters, BioInvent's revenue has decreased by 70.4%. Specifically, in Q4 2021's revenue was $ < 1M; in Q1 2022, it was $1.8M; in Q2 2022, it was $26.6M; in Q3 2022, BioInvent's revenue was $1.6M.